Abbott Laboratories Stock

Abbott Laboratories Current Liabilities

The Current Liabilities of Abbott Laboratories (ABT) as of Aug 20, 2026 is 26.52 B USD. In the previous year, Current Liabilities was 21.91 B USD — a change of 21.04% (higher).

Current Liabilities

26.52 BUSD

YoY

21.04%

Last updated:

Current Liabilities of Abbott Laboratories is 2026 26.52 B USD. Current Liabilities of Abbott Laboratories was 2025 21.91 B USD. It decreases by 21.04% higher compared to the previous year.
Access this data via the Eulerpool API

Abbott Laboratories Stock analysis

What does Abbott Laboratories do? Abbott Laboratories is one of the largest companies in the healthcare industry worldwide. The company was founded in 1888 by Dr. Wallace C. Abbott, who aimed to develop innovative and high-quality medical products that would improve people's lives and treat illnesses. Abbott Laboratories' business model is based on the discovery, development, manufacturing, and marketing of healthcare products. These range from pharmaceuticals to diagnostic devices. The company operates in various areas, including pharmaceuticals, nutrition, diagnostics, medical technology, and animal health. In the pharmaceutical field, Abbott Laboratories is a leading provider of generic drugs as well as innovative medications specialized in treating conditions such as Parkinson's disease, cancer, or hypertension. The company is particularly known for developing medications focused on the medical needs of women, such as hormone replacement therapy or birth control pills. In the nutrition field, Abbott Laboratories leads in the development of food and supplements for specific target groups, such as premature infants, cancer patients, or those with digestive problems. Best-selling products include Similac baby formula and Ensure, a nutritional supplement for older adults. In the diagnostics field, Abbott Laboratories develops and manufactures medical diagnostic devices and systems for patient monitoring. This includes blood glucose meters, blood pressure monitors, test strips, and laboratory systems for diagnosing diseases such as diabetes, HIV, or hepatitis. Abbott Laboratories is also a significant player in the medical technology field. The company produces and distributes medical devices such as pacemakers, stents, or artificial joints. These are typically used by doctors and hospitals to optimize patient treatment. In the animal health field, Abbott Laboratories offers a wide range of products and services for agricultural farms and veterinarians. This includes animal medications, pet food, diagnostics, and other services aimed at maintaining the health and well-being of livestock. Over the years, Abbott Laboratories has received numerous awards for its products and achievements. The company is committed to improving the quality of life for people worldwide and contributes to optimizing healthcare. Abbott Laboratories is among the top 15 leading pharmaceutical and healthcare companies worldwide and currently employs around 103,000 people in over 160 countries. Abbott Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Abbott Laboratories stock

Current Liabilities of Abbott Laboratories is 26.52 B USD in 2026.

Current Liabilities of Abbott Laboratories changed from 21.91 B USD to 26.52 B USD, representing a 21.04% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Abbott Laboratories since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Abbott Laboratories historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Abbott Laboratories

All Key Metrics — Abbott Laboratories